ABOUT US

PT Pyridam was founded by Ir. Sarkri Kosasih on November 27, 1976, based on Notarial Deed No. 31 by Tan Thong Kie in Jakarta, and initially focused on producing and marketing veterinary products through sales agents in several major cities across Indonesia.

The company diversified its business by producing and developing human medicines during the early stage of its expansion and was granted marketing rights by several overseas principals to distribute their medical equipment products in Indonesia, particularly in the laboratory equipment sector.

PT Pyridam veteriner was established to stay focused on the business of human medicine and laoratory apparatus/equipment.

Company built a factory (production facility) located in Desa Cibodas, Puncak, West Java.

The Company’s production factory began operations, and in the same year it conducted an IPO of 120,000,000 shares and was listed on the Jakarta Stock Exchange (now the Indonesia Stock Exchange). Following the IPO, the Company changed its name to PT Pyridam Farma Tbk. under Deed No. 267 dated December 23, 2000, approved by the Minister of Law and Human Rights of Indonesia.

The Company completed the preparation of Good Corporate Governance (GCG) in compliance with government regulations and relevant authorities, and published it on its website, including guidelines, board manual, code of conduct, risk management, audit committee charter, and internal audit unit charter.

Rejuve Global Investment Ltd acquired shares of PT Pyridam Farma Tbk, leading to changes in the company’s shareholder structure and management. In the same year, the company expanded into consumer health with the launch of its supplement brand, PYFAHEALTH.

The Company increased its ownership in PT Holi Pharma to nearly 100%, strengthening its pharmaceutical capabilities. In the same year, the Company expanded into the derma aesthetic segment with the launch of PYFAESTHETIC.

The Company acquired 100% ownership of PT Ethica Industri Farmasi, strengthening its manufacturing capabilities. In the same year, the Company launched Gerakan Sejuta Vitamin, an ESG-based CSR initiative aimed at improving public health access.

The Company completed the acquisition of Probiotec through Pyfa Australia Pty Ltd, marking a key step in its international expansion. In the same year, the Company launched multiple new business units across beauty retail, CDMO, Marketing Authorization, and prescription segments under the brands PYFABeauty, PYFACDMO, PYFAMAH, and PYFARx.

The Company significantly expanded the production capacity of PT Ethica Industri Farmasi, enhancing overall manufacturing output and improving operational efficiency across the group.